EUVIMEDEUVIMED entdecken
Crossref

Calycosin alleviates ovariectomy-induced osteoporosis by promoting BMSCs autophagy via the PI3K/Akt/mTOR pathway

Shouyu Xiang, Yinji Luo, Wei Liu, Cheng Tang, Tianyu Zhu, Lai Tian, Tiansheng Zheng, Long Ling, Mingyang Jia, Xing Li, Yanming Cao

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04009-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Shouyu Xiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510260, Guangdong Province, People's Republic o…. Hauptthemen laut MEDLINE: Isoflavones, Mesenchymal Stem Cells, Osteoporosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Science and Technology Program of Guangzhou, Natural Science Foundation of Guangdong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calycosin, the main extract from the traditional Chinese medicine (TCM) Astragalus membranaceus, has demonstrated anti-osteoporotic properties in ovariectomized (OVX) mice. However, the specific pathways through which it prevents osteoporosis remain unexplored. This study aimed to investigate the pathways by which calycosin promotes autophagy in bone marrow mesenchymal stem cells (BMSCs) and alleviates ovariectomy-induced osteoporosis. Mice were divided into three groups: sham, OVX, and OVX + calycosin. Following a 12-week intervention period, assessments included analysis of bone microstructure, serum concentrations of LC3II and ALP, and evaluation of Trap expression in femoral tissue. Immunohistochemical staining was used to assess the expression levels of PI3K, Runx2, and Beclin-1 in bone tissue. Additionally, levels of Runx2, ALP, p-PI3K, PI3K, mTOR, p-mTOR, Beclin-1, and ULK1 were analyzed. Osteogenic differentiation of BMSCs was evaluated using ALP and Alizarin red staining. OVX significantly impaired BMSCs osteogenic differentiation, resulting in bone loss. In contrast, calycosin increased bone mass, promoted osteogenesis, and reduced cancellous bone loss. Parameters, such as BMD, BV/TV, Tb.N, and Tb.Th, were significantly higher in the OVX + calycosin group compared to the OVX group. Additionally, Tb.Sp was notably reduced in the OVX + calycosin group. Calycosin also upregulated levels of Runx2, ALP, p-PI3K, p-mTOR, ULK1, and Beclin-1. In cellular studies, calycosin promoted BMSCs osteogenesis under OVX conditions; however, this effect was inhibited by LY294002. Calycosin effectively combats bone loss and improves bone structure. Its mechanism likely involves the promotion of autophagy in osteoblasts, thereby stimulating BMSC osteogenic differentiation. This effect may be mediated through the PI3K/Akt/mTOR pathway. These findings suggest that calycosin has the potential to serve as an alternative therapy for treating osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoflavonesMesenchymal Stem CellsOsteoporosisAnimalsTOR Serine-Threonine KinasesAutophagyFemaleOvariectomyProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesMiceOsteogenesisCells, CulturedBone DensityMice, Inbred C57BL

Stichwörter der Autor:innen

AutophagyBMSCsCalycosinOsteoporosisPI3K/Akt/mTOR pathway

Substanzen

TOR Serine-Threonine KinasesIsoflavones7,3'-dihydroxy-4'-methoxyisoflavoneProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesmTOR protein, mouse

Autor:innen und Institutionen

  • Department of Orthopedics, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510260, Guangdong Province, People's Republic of China.
  • Department of Orthopedics, Guilin People's Hospital, Guilin, China.
  • Department of Burns and Plastic Surgery, Shenzhen University General Hospital, Shenzhen, China.
  • The Zhushan People's Hospital, ShiYan, China.
  • Department of Endocrinology, Southern University of Science and Technology Hospital, Shenzhen, China.
  • Operating Room, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Förderung

  • Science and Technology Program of Guangzhou
  • Natural Science Foundation of Guangdong

Zitieren

APA

Xiang, S., Luo, Y., Liu, W., Tang, C., Zhu, T., Tian, L., Zheng, T., Ling, L., Jia, M., Li, X., & Cao, Y. (2025). Calycosin alleviates ovariectomy-induced osteoporosis by promoting BMSCs autophagy via the PI3K/Akt/mTOR pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04009-x

Vancouver

Xiang S, Luo Y, Liu W, Tang C, Zhu T, Tian L, et al. Calycosin alleviates ovariectomy-induced osteoporosis by promoting BMSCs autophagy via the PI3K/Akt/mTOR pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04009-x

BibTeX
@article{Xiang2025,
  author = {Xiang, Shouyu and Luo, Yinji and Liu, Wei and Tang, Cheng and Zhu, Tianyu and Tian, Lai and Zheng, Tiansheng and Ling, Long and Jia, Mingyang and Li, Xing and Cao, Yanming},
  title = {Calycosin alleviates ovariectomy-induced osteoporosis by promoting BMSCs autophagy via the PI3K/Akt/mTOR pathway},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04009-x}
}
Kostenlos starten →